The assisted reproductive
technology market was valued at USD 17.80 Billion in 2018 and is expected to
reach USD 43.14 Billion by 2026 growing at a Compound Annual Growth Rate (CAGR)
of 11.70% from 2018 to 2026. Rising work load and job pressure towards mankind are
increasing the disposable income of the global populations. However, this has
led to the rise in stress and physical distortion. In addition, the number of employed
female population is increasing with the advancement of days. Hence, lack of
mental relief and changes in lifestyles and food habits are increasing the
rates of infertility. The fertility of both male and female population is
reducing with the advancement of technologies and exposure of unhealthy food
habits. These are the major factors expected to drive the global assisted
reproductive technology market during the forecast period. Rise in the median
age of first-time conceiving is another factor proving to be a prime cause of
fertility defects which in turn will create new necessities and augment the
market of growth over the forecast period of 2018-2026.
The assisted reproductive
technology market has been segmented based on types which is further divided
IVF (In-Vitro Fertilization), GIFT (Gamete Intrafallopian Tube Transfer), IUI
(Intra Uterine Insemination) and Others. Based on end-user, the assisted
reproductive technology market has been segmented as fertility clinics and
hospitals. High success rates and increased public and private investment
towards setting up of IVF centers are expected to be the prime reasons for the IVF
segment to grow significantly during the forecast period. IVF segment has been
sub-segmented into ICSI (Intracytoplasmic Sperm Injection). ICSI segment is
expected to grow at fastest rate owing to the rising incidence of infertility
among men owing to the direct and passive smoking and excessive alcohol intake.
PGD (Preimplantation Genetic Diagnosis) has improved the success rate of IVF
and is further expected to propel the assisted reproductive technology significantly
owing to the rising awareness among prospective parents by eliminate
possibilities of genetically defective child birth.
The global assisted
reproductive technology market has been geographically segmented into
Asia-Pacific, Europe, North America, Latin America, the Middle East and Africa
region. In addition to this, Europe region holds the largest market share. The
reason may be attributed to the government initiatives, public awareness
regarding infertility and high rates of infertility. Investment towards bringing
advancement in fertilization technologies has further propelled the maker share
of Europe region. In addition, Asia Pacific assisted reproductive technology
market is expected to propel at the highest rate owing to the increasing
accessibility towards adopting advanced fertility services coupled with the
rise in tendency to lead western lifestyles. Countries across North America
region are increasing their investment towards research and developments of new
techniques of infertility management and the rise in the numbers of healthcare
institutes are expected to drive the North America assisted reproductive
technology market during the forecast period.
Some of the key players in the
global assisted reproductive technology market include Bloom IVF Centre,
CooperSurgical Inc., Cosmos Biomedical, Cryolab Ltd., European Sperm Bank,
Ferring B.V., Merck Group, Irvine Scientific., Microm UK Ltd. and Ovascience.
·
IVF
o
ICSI
·
GIFT
·
IUI
·
Others
·
Fertility Clinics
·
Hospitals
·
North America
o
U.S.
o
Canada
o
Mexico
·
Europe
o
U.K.
o
France
o
Germany
o
Italy
o
Rest of Europe
·
Asia Pacific
o
India
o
China
o
Japan
o
Rest of Asia Pacific
·
Middle East
and Africa
o
South Africa
o
Rest of Middle
East and Africa
·
Latin America
o
Brazil
o
Rest of Latin America
Customization options available to meet your custom research requirements :